The choice of antihypertensive therapy in correction of cognitive impairments and prevention of dementia: possibilities of valsartan and fixed-dose combination of valsartan and hydrochlorothiazide
This article discusses the definition, classification and pathogenetic mechanisms of cognitive functions in arterial hypertension. The authors discuss the capabilities of the different classes of antihypertensive drugs in correction of cognitive impairments and prevention of dementia. The authors al...
Main Authors: | Ostroumova O.D., Garelik I.A., Karavashkina E.A. |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Morozov P.V.
2016-12-01
|
Series: | Системные гипертензии |
Subjects: | |
Online Access: | http://syst-hypertension.ru/en/archive/2016/vol-13-4-2016/the-choice-of-antihypertensive-therapy-in-correction-of-cognitive-impairments-and-prevention-of-deme_1932/ |
Similar Items
-
The choice of antihypertensive therapy in correction of cognitive impairments and prevention of dementia: possibilities of valsartan and fixed-dose combination of valsartan and hydrochlorothiazide
by: O D Ostroumova, et al.
Published: (2016-12-01) -
The first results of an international clinical trial VICTORY:the efficacy and safety of antihypertensive valsartan monotherapy and the fixed combination of valsartan and hydrochlorothiazide usingdifferent dosage regimens in patients with 1-2 degree arterial hypertension
by: E Evgen'evna Chazova, et al.
Published: (2015-06-01) -
The results of the international clinical study VICTORY:efficacy and safety of antihypertensive monotherapy with valsartan (Valsacor®) and its fixed combination with hydrochlorothiazide(Valsacor® H)in routine clinical practice in patients with hypertens
by: Chazova I.E., et al.
Published: (2017-05-01) -
The results of the international clinical study VICTORY: efficacy and safety of antihypertensive monotherapy with valsartan (Valsacor®) and its fixed combination with hydrochlorothiazide (Valsacor® H) in routine clinical practice in patients with grade 1 and grade 2 hypertension
by: I E Chazova, et al.
Published: (2017-06-01) -
EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK
by: I. M. Sokolov, et al.
Published: (2015-12-01)